成人脓毒性休克ICU患者限制性静脉输液治疗的长期影响
该研究为CLASSIC试验的预设长期分析,纳入1554例成人脓毒性休克ICU患者,比较限制性与标准静脉输液治疗。1年死亡率限制性输液组为51.3%(385/746),标准输液组为49.9%(383/767),绝对风险差1.5个百分点(99%CI -4.8至7.8)。EQ-5D-5L指数值均值差0.00(99%CI -0.06至0.05),EQ VAS均值差-0.65(-5.40至4.08),Mini MoCA均值差-0.14(-1.59至1.14)。结论认为两组1年生存、健康相关生活质量和认知功能相似,但不能排除临床重要差异。
要点
- 1年死亡率限制性输液组51.3%(385/746)vs 标准输液组49.9%(383/767),绝对风险差1.5个百分点(99%CI -4.8至7.8)。
- EQ-5D-5L指数值均值差0.00(99%CI -0.06至0.05),EQ VAS均值差-0.65(99%CI -5.40至4.08),两组健康相关生活质量相似。
- Mini MoCA均值差-0.14(99%CI -1.59至1.14),两组认知功能相似。
- 仅存活者分析结果与总体相似。
- 作者结论:限制性与标准静脉输液治疗1年结局相似,但不能排除临床重要差异。
适用人群与场景
- 纳入CLASSIC试验的成人ICU脓毒性休克患者,共1554例随机分组。
研究设计与关键结果
- 预设分析CLASSIC试验长期结局,比较限制性与标准静脉输液治疗。
- 1年死亡率数据获取率97.9%,健康相关生活质量91.3%,认知功能86.3%。
- 1年死亡率:限制性输液组51.3%(385/746)vs 标准输液组49.9%(383/767),绝对风险差1.5个百分点(99%CI -4.8至7.8)。
- EQ-5D-5L指数值均值差0.00(99%CI -0.06至0.05),EQ VAS均值差-0.65(99%CI -5.40至4.08),Mini MoCA均值差-0.14(99%CI -1.59至1.14),均为限制性组 vs 标准组。
- 仅存活者分析两组结果相似。
证据类型、等级与局限
- 证据类型:CLASSIC试验的预设长期分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对成人ICU脓毒性休克患者,限制性与标准静脉输液治疗1年生存、健康相关生活质量和认知功能相似,但不能排除临床重要差异。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: To assess long-term outcomes of restrictive versus standard intravenous (IV) fluid therapy in adult intensive care unit (ICU) patients with septic shock included in the European Conservative versus Liberal Approach to Fluid Therapy in Septic Shock in Intensive Care (CLASSIC) trial.
METHODS: We conducted the pre-planned analyses of mortality, health-related quality of life (HRQoL) using EuroQol (EQ)-5D-5L index values and EQ visual analogue scale (VAS), and cognitive function using Mini Montreal Cognitive Assessment (Mini MoCA) test at 1 year. Deceased patients were assigned numerical zero for HRQoL as a state equal to death and zero for cognitive function outcomes as worst possible score, and we used multiple imputation for missing data on HRQoL and cognitive function.
RESULTS: Among 1554 randomized patients, we obtained 1-year data on mortality in 97.9% of patients, HRQoL in 91.3%, and cognitive function in 86.3%. One-year mortality was 385/746 (51.3%) in the restrictive-fluid group versus 383/767 (49.9%) in the standard-fluid group, absolute risk difference 1.5%-points [99% confidence interval (CI) - 4.8 to 7.8]. Mean differences were 0.00 (99% CI - 0.06 to 0.05) for EQ-5D-5L index values, - 0.65 for EQ VAS (- 5.40 to 4.08), and - 0.14 for Mini MoCA (- 1.59 to 1.14) for the restrictive-fluid group versus the standard-fluid group. The results for survivors only were similar in both groups.
CONCLUSIONS: Among adult ICU patients with septic shock, restrictive versus standard IV fluid therapy resulted in similar survival, HRQoL, and cognitive function at 1 year, but clinically important differences could not be ruled out.
参考来源
- Kjær MN, Meyhoff TS, Sivapalan P, et al. Long-term effects of restriction of intravenous fluid in adult ICU patients with septic shock. Intensive Care Med. 2023. PMID: 37330928. doi:10.1007/s00134-023-07114-8
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。